亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

G-Protein Inhibitors for Treatment of Atrial Fibrillation

技术优势
SelectivePotential forpersonalized AF therapy
详细技术说明
Treatment for atrial fibrillation (AF) by modulation of nerves in the heart muscle using inhibitors of G protein signaling #cardiology
*Abstract

In collaboration with industry partners, a scientist from Northwestern University has developed a novel strategy for treating atrial fibrillation (AF). Their innovative approach relies on modulating the autonomic nervous system in the heart using G protein inhibiting peptides, which enter the heart muscle and interrupt the aberrant signaling. Given that AF is the most common heart rhythm disorder, developing novel treatment modalities is imperative. In laboratory studies performed to date, G protein inhibiting peptides could be delivered by injection to selectively inhibit AF formation. This invention holds promise for development into a therapetic for AF, but may also contribute to G protein signaling and autonomic nervous system research fields.

*Inventors
Rishi Arora*Alan KadishAnnette Gilchrist
*Publications
Aistrup GL, Villuendas R,Ng J, Gilchrist A, Lynch TW, Gordon D, Cokic I, Zhou R, Dean DA, WasserstromJA, Goldberger JJ, Kadish AH, Arora R (2009) Targeted G-Protein Inhibition as aNovel Approach to Decrease Vagal Atrial Fibrillation by Selective ParasympatheticAttenuation, Cardivoascular Research,83: 481-92.
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备